A series of 2-(p-substituted phenyl)-5-[(4-substituted phenyl) sulfonylamido]-benzoxazoles were synthesized and tested for their antimicrobial activities. The structures of the new derivatives were elucidated by spectral techniques. The minimum inhibitory concentrations (MIC) of the new benzoxazoles were determined against standard bacterial and fungal strains and drug-resistant isolates and compared to those of several reference drugs.
INTRODUCTION
The treatment of infectious diseases still remains to be an important and challenging problem due to emerging infectious diseases and increasing number of multi-drug resistant microbial pathogens [3, 13] . In spite of the large number antibiotics and chemotherapeutics, the emergence of old and new antibiotic resistant bacterial strains constitutes a substantial need for the new class of potent antimicrobial agents [4, 11] .
Heterocyclic compounds play an important role in designing a new class of structural entities of medicinal importance with new mechanisms of action. Benzoxazoles, structural isosteres of natural nucleotides that can interact with biopolymers, constitute an important class of heterocyclic compounds with antimicrobial and antifungal activity [1-2, 9, 12, 14-17] .
A benzoxazole derivative; calcimycin is a carboxylic polyether antibiotic from a strain of Streptomyces chartreusis (NRRL 3882). It was found to be very active against Gram-positive bacteria including some Bacillus, Micrococcus strains [12] . Routiennocin, 3-hydroxy-11,15-desmethyl analog of calcimycin and cezomycin, 3-demethylamino analog of calcimycin are found to be highly active against Bacillus cereus, B. negaterium, Micrococcus luteus and Streptomyces rimosus [14] . Additionaly frankamide; 11-demethyl cezomycin is another calcimycin analogue which has activ-ity against B. subtilis, Staphylococcus aureus, Enterococcus faecalis and against several plant pathogenic fungal strains [9] .
In the last years we described the synthesis of different derivatives of some 2,5-di substituted benzoxazoles and the results of assays on their in vitro antimicrobial activity against some Gram-positive, Gram-negative bacteria and fungus Candida albicans [1] [2] [15] [16] [17] . In the present study, we report a new series of 2-(p-sub stituted phenyl)-5-[(4-substituted phenyl) sulfonylamido]-benzoxazoles. 2-19 has been synthesized using a two-step procedure. Several control drugs and new synthesized benzoxazole compounds were evaluated for their antibacterial and antifungal activity against standard strains and their drug-resistant isolates.
MATERIALS AND METHODS

Chemistry
Chemicals and solvents were purchased from Sigma-Aldrich (Munich, Germany) and Fisher Scientific (Pittsburgh, PA, USA), and used without further purification. Silica gel HF 254 chromatoplates (0.3 mm) were used for thin layer chromatography, and chloroform was employed as mobile phase. Melting points were recorded on a Stuart Scientific SMP 1 instrument (Bibby Scientific Limited, Stone, Staffordshire, UK) and are uncorrected. NMR spectra were recorded on a Varian Mercury 400 MHz NMR For microbiological assays, stock solutions of the test compounds were prepared in DMSO. Antibiotic solutions were prepared according to the guideline of CLSI M100-S18. Antimicrobial susceptibility testing was performed through CLSI M100-S18 [5] and CLSI M27-A3 [6] directions. Bacterial isolates were subcultured in MHA plates and incubated over night at 37 °C and C. albicans was subcultured in SDA plates at 35 °C for 24-48 h. The microorganisms were passaged at least twice to ensure purity and viability. Pure colonies were transferred to MHB and SLM for bacteria and fungi, respectively. They were incubated in the appropriate conditions overnight. After incubation, the bacterial suspensions used for inoculation were prepared at 10 5 CFU/mL by diluting fresh cultures at MacFarland 0.5 density (10 7 CFU/ mL). Yeast suspensions were also prepared according to McFarland 0.5 density and a working suspension was made by a 1 : 100 dilution followed by a 1 : 20 dilution of the stock suspension (2.5 × 10 3 CFU/mL). Susceptibility testing was performed with MHB for bacteria and RPMI-1640 medium with L-glutamine buffered pH 7 with MOPS for fungi. The solution of the newly synthesized compounds and standard Table 1 Physical and spectral data of the newly synthesized benzoxazole derivatives* After dilution, a 10 µL bacterial or fungal inoculum was added to each well of the microdilution trays. The trays were incubated at 37 °C for bacteria and 35 °C for fungi, in a humid chamber and MIC endpoints were read after 24 h of incubation. The lowest concentration of the compound that completely inhibits macroscopic growth was determined and minimum inhibitory concentrations (MICs) were reported. All organisms were tested in triplicate in each run of the experiments. Solvents, pure microorganisms and pure media were used as control wells.
RESULTS
The desired benzoxazole derivatives were synthesized using a two-step procedure. Firstly, 5-amino-2-(p-substituted phenyl)-benzoxazoles were synthesized by heating 2,4-diaminophenol with p-substituted benzoic acid in polyphosphoric acid (PPA). Then compounds 2-19 were obtained by treating a solution of p-substituted-benzenesulfonyl chlorides with 5-amino-2-(p-substituted phenyl)-benzoxazoles as shown in Fig. 1 .
Their structures were elucidated with Mass, 1 H NMR and 13 C NMR spectroscopy. Their purity was analyzed through elemental analysis that was within ±0.4% of theoretical values. Physical and spectral data of the synthesized benzoxazole derivatives are given in Table 1 . In the 1 H NMR spectra of the compounds (2-19) of the signal of the NH proton was observed at 10.70-10.10 ppm as a singlet band, aromatic OCH 3 protons were observed at 3.74-3.80 as singlet band for compounds 4, 10. Aromatic CH 3 protons appeared at 2.31-2.30 ppm as singlet band for compounds 3, 14, 16. Besides all the aromatic protons were observed at the expected regions. On the other hand, mass spectra of the compounds showed M + +H, M + , M + -H peaks, since the electrospray ionization method was employed, in accordance with their formulas. Additionally, 13 C NMR spectra of compounds were evaluated.
All the newly synthesized benzoxazoles (2-19) and standard drugs were evaluated for their antimicrobial activity against some Gram-positive, Gram-negative bacteria and fungus C. albicans and their drug-resistant isolates. The results are presented in Table 2 .
DISCUSSION
In the last few years, we described the synthesis of some 2,5-disubstituted-benzoxazoles and the results of assays on their in vitro antimicrobial activity against some Gram-positive, Gram-negative bacteria, along with the microfungus C. albicans and their isolates [ 
